Stempoint Capital LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Stempoint Capital LP disclosed 50 US equity positions worth $333.4m in its Q3 2024 13F filing. The largest position was SNDX at 10.0% of the reported book, followed by ROIV and MERUS N V.
What did Stempoint Capital LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 10.0% | $33.3m | 1,731,191 | – | |
| 2 | ROIV ROIVANT SCIENCES LTD | Healthcare | 9.6% | $32.0m | 2,769,819 | – | |
| 3 | MERUS N V | 6.3% | $21.0m | 421,222 | – | ||
| 4 | IMVT IMMUNOVANT INC | Healthcare | 5.7% | $19.1m | 671,001 | – | |
| 5 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 5.0% | $16.5m | 1,778,318 | – | |
| 6 | AM6 AMICUS THERAPEUTICS INC | 4.7% | $15.8m | 1,481,809 | – | ||
| 7 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 4.3% | $14.2m | 275,303 | – | |
| 8 | APLT APPLIED THERAPEUTICS INC | 4.0% | $13.2m | 1,554,586 | – | ||
| 9 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 3.3% | $10.9m | 213,815 | – | ||
| 10 | BHVN BIOHAVEN LTD | Healthcare | 3.2% | $10.8m | 216,440 | – | |
| 11 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.0% | $10.0m | 174,034 | – | |
| 12 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 2.8% | $9.5m | 2,616,602 | – | |
| 13 | INCY INCYTE CORP | Healthcare | 2.6% | $8.6m | 129,490 | – | |
| 14 | DNLI DENALI THERAPEUTICS INC | Healthcare | 2.5% | $8.2m | 282,050 | – | |
| 15 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 2.1% | $7.1m | 506,978 | – | ||
| 16 | ACELYRIN INC | 1.9% | $6.5m | 1,317,854 | – | ||
| 17 | SLNOEUR SOLENO THERAPEUTICS INC | 1.9% | $6.2m | 123,177 | – | ||
| 18 | CABA CABALETTA BIO INC | Healthcare | 1.8% | $6.0m | 1,278,444 | – | |
| 19 | IMTX IMMATICS N.V | Healthcare | 1.5% | $5.1m | 449,735 | – | |
| 20 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.5% | $5.0m | 86,930 | – | |
| 21 | ACLXGBX ARCELLX INC | 1.5% | $5.0m | 60,076 | – | ||
| 22 | VTGN VISTAGEN THERAPEUTICS INC | 1.5% | $4.9m | 1,846,792 | – | ||
| 23 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.4% | $4.6m | 203,015 | – | |
| 24 | TCRX TSCAN THERAPEUTICS INC | 1.3% | $4.3m | 860,951 | – | ||
| 25 | ZURA ZURA BIO LTD | Healthcare | 1.3% | $4.2m | 1,044,168 | – | |
| 26 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.3% | $4.2m | 132,703 | – | |
| 27 | 430 TERNS PHARMACEUTICALS INC | 1.1% | $3.7m | 449,321 | – | ||
| 28 | CATX PERSPECTIVE THERAPEUTICS INC | 1.0% | $3.2m | 238,084 | – | ||
| 29 | PYXS PYXIS ONCOLOGY INC | 0.9% | $3.1m | 850,210 | – | ||
| 30 | NGNE NEUROGENE INC | 0.9% | $3.1m | 73,299 | – | ||
| 31 | URGN UROGEN PHARMA LTD | Healthcare | 0.9% | $3.1m | 241,984 | – | |
| 32 | VIGL VIGIL NEUROSCIENCE INC | 0.8% | $2.5m | 743,719 | – | ||
| 33 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 0.7% | $2.5m | 300,000 | – | |
| 34 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.7% | $2.4m | 94,885 | – | |
| 35 | JANX JANUX THERAPEUTICS INC | Healthcare | 0.7% | $2.2m | 49,415 | – | |
| 36 | SRZN SURROZEN INC | 0.7% | $2.2m | 182,918 | – | ||
| 37 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 0.6% | $2.2m | 41,268 | – | |
| 38 | HELIX ACQUISITION CORP II | 0.6% | $2.1m | 200,000 | – | ||
| 39 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.6% | $1.9m | 15,014 | – | |
| 40 | TARA PROTARA THERAPEUTICS INC | 0.5% | $1.7m | 942,857 | – | ||
| 41 | PERCEPTIVE CAP SOLUTIONS COR | 0.5% | $1.5m | 150,000 | – | ||
| 42 | TRML TOURMALINE BIO INC | 0.4% | $1.4m | 55,523 | – | ||
| 43 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 0.4% | $1.4m | 93,638 | – | |
| 44 | ALKS ALKERMES PLC | Healthcare | 0.4% | $1.4m | 48,918 | – | |
| 45 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.4% | $1.3m | 83,662 | – | ||
| 46 | MBX MBX BIOSCIENCES INC | Healthcare | 0.4% | $1.3m | 50,000 | – | |
| 47 | CYTK CYTOKINETICS INC | Healthcare | 0.2% | $763.7k | 14,464 | – | |
| 48 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.2% | $755.3k | 16,654 | – | |
| 49 | CATBUSD ASTRIA THERAPEUTICS INC | 0.2% | $618.9k | 56,287 | – | ||
| 50 | EWTX EDGEWISE THERAPEUTICS INC | 0.2% | $531.1k | 19,900 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.